Facebook-f Twitter Instagram Podcast Youtube Tiktok Linkedin-in Pinterest Envelope Share
CLICK HERE TO SHARE YOUR STORY!
  • About
    • Meet Our Contributors
    • Meet Our Partners
    • Meet the Patient Worthy Team
    • Collaborative Content On Patient Worthy
  • Diseases
  • Share Your Story
    • Patient Worthy Content Submission Guidelines
    • Patient Worthy Writing Prompts
    • Submit Your Story
    • Patient Stories
  • Resources
    • Library
    • Events
    • Patient Worthy FAQs
  • Podcast
  • Contact
Menu
  • About
    • Meet Our Contributors
    • Meet Our Partners
    • Meet the Patient Worthy Team
    • Collaborative Content On Patient Worthy
  • Diseases
  • Share Your Story
    • Patient Worthy Content Submission Guidelines
    • Patient Worthy Writing Prompts
    • Submit Your Story
    • Patient Stories
  • Resources
    • Library
    • Events
    • Patient Worthy FAQs
  • Podcast
  • Contact
  • Join PW

preclinical studies

  1. Home>
  2. preclinical studies
SBT-272 Offers Mitochondrial Protection in ALS
argzombies / Pixabay

SBT-272 Offers Mitochondrial Protection in ALS

  • Post author:Jessica Lynn
  • Post published:October 27, 2021
  • Post category:Amyotrophic Lateral Sclerosis/Progressive Supranuclear Palsy

From October 6-7, 2021, researchers and stakeholders descended upon the virtual Northeast Amyotrophic Lateral Sclerosis Meeting to discuss new trends, research, and therapies within the field. According to ALS News…

Continue Reading SBT-272 Offers Mitochondrial Protection in ALS
Ketamine Earns Orphan Drug Status for ALS
Source: https://unsplash.com/photos/e9mNqZtBogU

Ketamine Earns Orphan Drug Status for ALS

  • Post author:Jessica Lynn
  • Post published:August 17, 2021
  • Post category:Amyotrophic Lateral Sclerosis

  In 1970, ketamine was used to treat injured soldiers on the tail end of the Vietnam War. The treatment helps relieve pain, but doesn't affect cardiac or respiratory function.…

Continue Reading Ketamine Earns Orphan Drug Status for ALS
Combination Therapy Reduces LCH Burden
moreharmony / Pixabay

Combination Therapy Reduces LCH Burden

  • Post author:Jessica Lynn
  • Post published:July 6, 2021
  • Post category:Langerhans Cell Histiocytosis

In patients with rare or underserved conditions, it can sometimes be difficult to receive effective treatment. For example, chemotherapy, the standard-of-care for Langerhans cell histiocytosis (LCH), is only effective in…

Continue Reading Combination Therapy Reduces LCH Burden
Pre-Clinical Data Shows Zika Virus Vaccine Efficacy
kfuhlert / Pixabay

Pre-Clinical Data Shows Zika Virus Vaccine Efficacy

  • Post author:Jessica Lynn
  • Post published:April 15, 2021
  • Post category:Zika Virus

According to Drug Target Reviews, there may be an emerging vaccination effective against preventing Zika virus infection. Though many cases are mild, the infection can cause severe birth defects and…

Continue Reading Pre-Clinical Data Shows Zika Virus Vaccine Efficacy
Patent Granted for DYN101 for Centronuclear Myopathy
edar / Pixabay

Patent Granted for DYN101 for Centronuclear Myopathy

  • Post author:Jessica Lynn
  • Post published:January 29, 2021
  • Post category:Centronuclear myopathy- congenital

In late January 2021, Dynacure, a clinical-stage drug development company focused on rare diseases, announced that it was granted a patent (U.S. Patent No. US 10, 865, 414) for its…

Continue Reading Patent Granted for DYN101 for Centronuclear Myopathy
Finding Light Through Story-The Power of Ambassadorship in the Endometrial Cancer Community
*cancer that cannot be removed with surgery or has spread to other parts of the body. GEJ= gastroesophageal junction (where the esophagus joins the stomach)
CLICK HERE TO SHARE YOUR STORY!
We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.
Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Partner With Us
Submit a Story

Keep Up to Date

Subscribe to Our Newsletter
Check Out Rare Events
Get Inspired By Our Memes

Learn More

About Us
Rare Diseases and Conditions
Terms of Use
Privacy Notice
Privacy Policy for CA Residents
EU/UK Privacy Notice
Data Privacy Framework: Consumer Privacy Policy
Consumer Health Data Privacy Policy
Cookie Notice

Facebook-f Twitter Instagram Podcast Youtube Tiktok Linkedin-in Pinterest Envelope

© Copyright 2024 Patient Worthy

Sign Up With a Patient Worthy Account and Share Your Rare Story

- OR -

Sign Up For Our Patient Panel

Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.

More Info

We're Happy You're Here!

What best describes you when it comes to rare disease? (check all that apply)

What rare disease(s)/conditions are most important to you?

Visit Home Page or

Thank you for signing up for a Patient Worthy Account!

Have a rare disease story to share? Let us know

Share Story

- OR -

Sign Up For Our Patient Panel

Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.

More Info